ID   SET1_CAEEL              Reviewed;         242 AA.
AC   Q22795;
DT   23-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1999, sequence version 2.
DT   10-FEB-2021, entry version 140.
DE   RecName: Full=Histone-lysine N-methyltransferase set-1;
DE            EC=2.1.1.361 {ECO:0000255|PROSITE-ProRule:PRU00904, ECO:0000269|PubMed:23028348};
GN   Name=set-1; ORFNames=T26A5.7;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [2]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=12119097; DOI=10.1016/s0378-1119(02)00671-6;
RA   Terranova R., Pujol N., Fasano L., Djabali M.;
RT   "Characterisation of set-1, a conserved PR/SET domain gene in
RT   Caenorhabditis elegans.";
RL   Gene 292:33-41(2002).
RN   [3]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=22393255; DOI=10.1128/mcb.06546-11;
RA   Wells M.B., Snyder M.J., Custer L.M., Csankovszki G.;
RT   "Caenorhabditis elegans dosage compensation regulates histone H4 chromatin
RT   state on X chromosomes.";
RL   Mol. Cell. Biol. 32:1710-1719(2012).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=23028348; DOI=10.1371/journal.pgen.1002933;
RA   Vielle A., Lang J., Dong Y., Ercan S., Kotwaliwale C., Rechtsteiner A.,
RA   Appert A., Chen Q.B., Dose A., Egelhofer T., Kimura H., Stempor P.,
RA   Dernburg A., Lieb J.D., Strome S., Ahringer J.;
RT   "H4K20me1 contributes to downregulation of X-linked genes for C. elegans
RT   dosage compensation.";
RL   PLoS Genet. 8:E1002933-E1002933(2012).
RN   [5]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=23884442; DOI=10.1242/dev.094292;
RA   Webster C.M., Wu L., Douglas D., Soukas A.A.;
RT   "A non-canonical role for the C. elegans dosage compensation complex in
RT   growth and metabolic regulation downstream of TOR complex 2.";
RL   Development 140:3601-3612(2013).
RN   [6]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=28867287; DOI=10.1016/j.cell.2017.07.041;
RA   Brejc K., Bian Q., Uzawa S., Wheeler B.S., Anderson E.C., King D.S.,
RA   Kranzusch P.J., Preston C.G., Meyer B.J.;
RT   "Dynamic Control of X Chromosome Conformation and Repression by a Histone
RT   H4K20 Demethylase.";
RL   Cell 171:E23-E23(2017).
CC   -!- FUNCTION: Histone methyltransferase that specifically monomethylates
CC       'Lys-20' of histone H4 (H4K20me1) (PubMed:23028348). H4K20me1 is
CC       enriched on hermaphrodite X chromosomes and during mitosis
CC       (PubMed:23028348, PubMed:22393255). Involved in dosage compensation by
CC       repression of X-linked gene expression in hermaphrodites
CC       (PubMed:23028348). Plays a role in growth and body fat regulation
CC       downstream of the TOR complex 2 pathway (PubMed:23884442).
CC       {ECO:0000269|PubMed:22393255, ECO:0000269|PubMed:23028348,
CC       ECO:0000269|PubMed:23884442}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-lysyl(20)-[histone H4] + S-adenosyl-L-methionine = H(+) +
CC         N(6)-methyl-L-lysyl(20)-[histone H4] + S-adenosyl-L-homocysteine;
CC         Xref=Rhea:RHEA:60344, Rhea:RHEA-COMP:15554, Rhea:RHEA-COMP:15555,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789, ChEBI:CHEBI:61929; EC=2.1.1.361;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00904,
CC         ECO:0000269|PubMed:23028348};
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12119097}. Chromosome
CC       {ECO:0000305|PubMed:23028348}.
CC   -!- TISSUE SPECIFICITY: In embryos, it is expressed ubiquitously. In late
CC       embryos, it is expressed in hypodermal seam cells. In L3 and L4 larvae
CC       and thereafter, it is expressed in vulval precursor cells. In adult
CC       males, it is also expressed in 6 unidentified posterior cells.
CC       {ECO:0000269|PubMed:12119097}.
CC   -!- DEVELOPMENTAL STAGE: Highly expressed in eggs, then decreases.
CC       {ECO:0000269|PubMed:12119097}.
CC   -!- DISRUPTION PHENOTYPE: Mutant animals lack methylation of 'Lys-20' of
CC       histone H4 (H4K20me) (PubMed:23028348). In a glp-1(e2141) mutant
CC       background which lacks a germline, the X-linked genes aco-1, ajm-1 and
CC       apl-1 are up-regulated (PubMed:23028348). RNAi-mediated knockdown leads
CC       to embryonic lethality in a mutant background of the dosage
CC       compensation proteins dpy-21 or dpy-28 (PubMed:23028348). Increases
CC       'Lys-16' acetylation of histone H4 on hermaphrodite X chromosomes
CC       (PubMed:22393255). In the TOR complex 2 mutant background rict-1,
CC       suppresses the growth delay and elevated body fat index
CC       (PubMed:23884442). Causes mitotic chromosome segregation defects and
CC       chromosome bridges resulting in delayed or arrested embryonic
CC       development and embryonic lethality (PubMed:28867287).
CC       {ECO:0000269|PubMed:22393255, ECO:0000269|PubMed:23028348,
CC       ECO:0000269|PubMed:23884442, ECO:0000269|PubMed:28867287}.
CC   -!- SIMILARITY: Belongs to the class V-like SAM-binding methyltransferase
CC       superfamily. Histone-lysine methyltransferase family. PR/SET subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00904}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; FO080366; CCD63213.1; -; Genomic_DNA.
DR   PIR; T34384; T34384.
DR   RefSeq; NP_001022796.1; NM_001027625.3.
DR   SMR; Q22795; -.
DR   BioGRID; 41136; 14.
DR   IntAct; Q22795; 12.
DR   STRING; 6239.T26A5.7a; -.
DR   EPD; Q22795; -.
DR   PaxDb; Q22795; -.
DR   EnsemblMetazoa; T26A5.7a.1; T26A5.7a.1; WBGene00004781.
DR   GeneID; 175918; -.
DR   KEGG; cel:CELE_T26A5.7; -.
DR   UCSC; T26A5.7b.1; c. elegans.
DR   CTD; 175918; -.
DR   WormBase; T26A5.7a; CE19602; WBGene00004781; set-1.
DR   eggNOG; KOG1085; Eukaryota.
DR   GeneTree; ENSGT00940000163293; -.
DR   HOGENOM; CLU_047978_2_1_1; -.
DR   InParanoid; Q22795; -.
DR   OMA; KWCIDAT; -.
DR   OrthoDB; 1460495at2759; -.
DR   PhylomeDB; Q22795; -.
DR   Reactome; R-CEL-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-CEL-3214841; PKMTs methylate histone lysines.
DR   PRO; PR:Q22795; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00004781; Expressed in multi-cellular organism and 7 other tissues.
DR   ExpressionAtlas; Q22795; baseline and differential.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:WormBase.
DR   GO; GO:0018024; F:histone-lysine N-methyltransferase activity; IEA:InterPro.
DR   GO; GO:0009792; P:embryo development ending in birth or egg hatching; IMP:WormBase.
DR   InterPro; IPR016858; Hist_H4-K20_MeTrfase.
DR   InterPro; IPR001214; SET_dom.
DR   Pfam; PF00856; SET; 1.
DR   PIRSF; PIRSF027717; Histone_H4-K20_mtfrase; 1.
DR   SMART; SM00317; SET; 1.
DR   PROSITE; PS51571; SAM_MT43_PR_SET; 1.
DR   PROSITE; PS50280; SET; 1.
PE   1: Evidence at protein level;
KW   Chromatin regulator; Chromosome; Methyltransferase; Nucleus;
KW   Reference proteome; S-adenosyl-L-methionine; Transcription;
KW   Transcription regulation; Transferase.
FT   CHAIN           1..242
FT                   /note="Histone-lysine N-methyltransferase set-1"
FT                   /id="PRO_0000097694"
FT   DOMAIN          104..226
FT                   /note="SET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT   REGION          114..116
FT                   /note="S-adenosyl-L-methionine binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00904"
FT   REGION          186..187
FT                   /note="S-adenosyl-L-methionine binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00904"
FT   COMPBIAS        18..21
FT                   /note="Poly-Ala"
FT   COMPBIAS        38..43
FT                   /note="Poly-Ser"
FT   BINDING         159
FT                   /note="S-adenosyl-L-methionine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190,
FT                   ECO:0000255|PROSITE-ProRule:PRU00904"
SQ   SEQUENCE   242 AA;  27568 MW;  0F752B79505AFA99 CRC64;
     MKVAAKKLAT SRMRKDRAAA ASPSSDIENS ENPSSLASHS SSSGRMTPSK NTRSRKGVSV
     KDVSNHKITE FFQVRRSNRK TSKQISDEAK HALRDTVLKG TNERLLEVYK DVVKGRGIRT
     KVNFEKGDFV VEYRGVMMEY SEAKVIEEQY SNDEEIGSYM YFFEHNNKKW CIDATKESPW
     KGRLINHSVL RPNLKTKVVE IDGSHHLILV ARRQIAQGEE LLYDYGDRSA ETIAKNPWLV
     NT
//
